STRUCTURE-BASED INHIBITORS OF BRCA1 TO ENHANCE THE BREAST CANCER SENSITIVITY TO RADIATION THERAPY AND CHEMOTHERAPYY

$637,500FY2010Department of the ArmyDOD

Beth Israel Deaconess Medical Center, Inc.

Investigators